<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5589D756-E334-47E6-9A29-7932ED64B2A1"><gtr:id>5589D756-E334-47E6-9A29-7932ED64B2A1</gtr:id><gtr:name>Valencia University</gtr:name><gtr:address><gtr:line1>Valencia University</gtr:line1><gtr:line2>Avda. Bianca Ibanez 13</gtr:line2><gtr:line4>Valencia</gtr:line4><gtr:postCode>46010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5589D756-E334-47E6-9A29-7932ED64B2A1"><gtr:id>5589D756-E334-47E6-9A29-7932ED64B2A1</gtr:id><gtr:name>Valencia University</gtr:name><gtr:address><gtr:line1>Valencia University</gtr:line1><gtr:line2>Avda. Bianca Ibanez 13</gtr:line2><gtr:line4>Valencia</gtr:line4><gtr:postCode>46010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/840EFE80-350A-4CEC-9E3C-9170F97C3761"><gtr:id>840EFE80-350A-4CEC-9E3C-9170F97C3761</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Wade-Martins</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/434630DA-F0E3-406B-B4DA-87FBDEF552FD"><gtr:id>434630DA-F0E3-406B-B4DA-87FBDEF552FD</gtr:id><gtr:firstName>Keith</gtr:firstName><gtr:surname>Channon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400144"><gtr:id>518D2994-A714-4153-847C-6888BDF3D4A3</gtr:id><gtr:title>Low density lipoprotein receptor genomic locus delivery for the treatment of familial hypercholesterolaemia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400144</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>234906</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Cardiovascular Medicine</gtr:department><gtr:description>Gene therapy for familial hypercholesterolaemia</gtr:description><gtr:id>C05EDE21-94FD-47D1-B751-F5CE0EA2F414</gtr:id><gtr:impact>Outputs: 
1. The papers listed in the Publications section 
2. An estimated eight conference abstracts 
3. Three follow-on grants from the British Heart Foundation, totalling approximately &amp;pound;330,000</gtr:impact><gtr:outcomeId>34A1CCDFE6E-1</gtr:outcomeId><gtr:partnerContribution>Expertise of in vivo gene function analysis</gtr:partnerContribution><gtr:piContribution>Members of the Cardiovascular Medicine Department, University of Oxford, have become close and invaluable collaborators as a direct result of my MRC funded project into gene therapy for familial hypercholesterolaemia</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Medicinal chemistry collaboration</gtr:description><gtr:id>146EFBEB-749F-43C8-9F62-F0166608EE87</gtr:id><gtr:impact>BHF PhD studentship</gtr:impact><gtr:outcomeId>mbgk7Cb8HPF-1</gtr:outcomeId><gtr:partnerContribution>Developed a collaboration with medicinal chemists at Oxford to generate compounds as potential therapies for FH</gtr:partnerContribution><gtr:piContribution>Screening of molecules produced by the chemists in cell culture</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Clinical Pharmacology</gtr:department><gtr:description>Luciferase imaging in vivo in the liver</gtr:description><gtr:id>9DFA4BF4-092E-41C5-AA0B-2435ECDB0B1D</gtr:id><gtr:impact>PubMed 19861949
We have obtained funds to purchase a joint-share in a luciferase imaging machine
We have developed the techniques with further BHF project grant funding</gtr:impact><gtr:outcomeId>8A32FBC85CE-1</gtr:outcomeId><gtr:partnerContribution>We have together developed in Oxford the technique of non-invasive monitoring of gene expression in the over using hydrodynamic gene delivery and luciferase imaging.</gtr:partnerContribution><gtr:piContribution>We have developed in Oxford the technique of non-invasive monitoring of gene expression in the over using hydrodynamic gene delivery and luciferase imaging.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Heart &amp; Lung Institute (NHLI)</gtr:department><gtr:description>Hydrodynamic gene delivery</gtr:description><gtr:id>7BB372E7-4298-4A17-9693-E0E28B7F736C</gtr:id><gtr:impact>The impacts have been multiple and long-lasting. Three of the publications (19861949, 18800153, and 19861949) were a direct result of the collaboration. We have worked together on further development of various gene delivery and gene therapy vectors, most recently the SMAR episomal vector systems</gtr:impact><gtr:outcomeId>CF063CC3DCD-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators at Imperial College taught us the technique of hydrodynamic gene delivery which we have then passed on to numerous groups at the University of Oxford</gtr:partnerContribution><gtr:piContribution>We have enjoyed a long-standing collaboration with our gene therapy colleagues at Imperial College, London. The group taught us the methods of hydrodynamic gene delivery which proved essential for developing our work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Valencia</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Cell cycle dependent gene expression in the liver</gtr:description><gtr:id>D3F2272F-6098-4FFE-B39F-76F41C555BE8</gtr:id><gtr:impact>The work formed part of the student's doctoral thesis and will be submitted for publication. The paper will shortly be submitted.</gtr:impact><gtr:outcomeId>F85FE55D84A-1</gtr:outcomeId><gtr:partnerContribution>A visiting scientist from Valencia spent three months in our laboratory to learn methods of gene delivery.</gtr:partnerContribution><gtr:piContribution>A PhD student scientist visiting from Valencia, spent three months in our laboratory learning in vivo hydrodynamic gene delivery to the liver.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>I am a scientist get me out of here</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>692CADF4-86AE-4D55-BCF3-C87B8F9DE741</gtr:id><gtr:impact>OHC, the post-doctoral scientist on the project, took part in the web-based event &amp;quot;I am a scientist get me out of here&amp;quot; competition and came runner-up nationally.

OHC was subsequently interviewed very successfully on BBC Radio Oxford</gtr:impact><gtr:outcomeId>D1311658B88</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit Oxford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>4528072E-C123-4340-812F-754B05662600</gtr:id><gtr:impact>I attended Radley College near Oxford and spoke on gene therapy and molecular medicine.

Increased awareness of a extremely important topic amongst school science students.</gtr:impact><gtr:outcomeId>06A7B791F6C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Bristol</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>8923A6E5-E9E6-4587-A3EE-00A90D69A5AD</gtr:id><gtr:impact>I attended Churchill Community College near Bristol and spoke on gene therapy and molecular medicine.

Increased awareness of a extremely important topic amongst school science students</gtr:impact><gtr:outcomeId>D0BF2668412</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science in the Kitchen</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>DD9A7389-B457-4049-B700-B6A435490336</gtr:id><gtr:impact>I contributed to a genetics awareness event run by the Wellcome Trust Centre for Human Genetics, University of Oxford

Increased public awareness of the impact of genetics in medicine today</gtr:impact><gtr:outcomeId>A5F7F57345E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Norwich</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>3E37199B-35F8-45ED-9C48-7895F4DC0D89</gtr:id><gtr:impact>I attended Norwich School and spoke on gene therapy and molecular medicine.

Increased awareness of a extremely important topic amongst school science students.</gtr:impact><gtr:outcomeId>E96AC2D9F24</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>155000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>D54A9AF6-7572-4BDD-9C70-F458984B2F7C</gtr:id><gtr:outcomeId>NGwtP7BTuok0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Pilot grant (Centre for Research Excellence)</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>611F0316-E924-4011-8615-947D27BD0A23</gtr:id><gtr:outcomeId>5F9916B18570</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>78315</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>2E417056-FD97-45B2-B5F5-C482082A3FD6</gtr:id><gtr:outcomeId>C0984BA318C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53329</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2009-02-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>B0F23997-FBE7-4757-9856-BDF7A4627E48</gtr:id><gtr:outcomeId>4FCC6E2AD880</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF PhD Studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>327191D1-3C2B-4F13-BB7C-52754704EFC1</gtr:id><gtr:outcomeId>B5hZsy4N5ed</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Our research group has developed a new class of gene therapy vector, one in which a transgene is expressed from the native promoter allowing complete physiological regulation of the transgene. Such a methodology will be critical for developing gene therapy for a range of diseases, likely recessive metabolic diseases. We are also developing reporter gene versions to use in drug screens to find compounds to alleviate hypercholesterolaemia in patients.</gtr:description><gtr:id>22099E3D-94B9-43C3-B7BC-D10E1D77E5A0</gtr:id><gtr:impact>Data from our vectors has been published and presented as oral presentations at numerous national and international meetings.</gtr:impact><gtr:outcomeId>DDABEF32B1B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Regulatable gene therapy vectors</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0D15B396-59E7-428B-8D82-32B51A9B10B2</gtr:id><gtr:title>RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/880cc9bd62bf59ae6d0a8bcf94a8ff94"><gtr:id>880cc9bd62bf59ae6d0a8bcf94a8ff94</gtr:id><gtr:otherNames>Hibbitt O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>BND33mo176F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D74CC182-C3E3-4325-8670-5A9823441160</gtr:id><gtr:title>Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f056c409aede7073750d20c637e7b07f"><gtr:id>f056c409aede7073750d20c637e7b07f</gtr:id><gtr:otherNames>Hibbitt OC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>E57F8D211B9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30E576AB-507C-43A9-B9DE-A257C7DA0DEB</gtr:id><gtr:title>Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f056c409aede7073750d20c637e7b07f"><gtr:id>f056c409aede7073750d20c637e7b07f</gtr:id><gtr:otherNames>Hibbitt OC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>BF44854F28E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F8DCA46-48FE-4F67-9DB8-8212F5172195</gtr:id><gtr:title>An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adeffd7eeee062f1aa43b9711d261a77"><gtr:id>adeffd7eeee062f1aa43b9711d261a77</gtr:id><gtr:otherNames>Lufino MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>C8E0E7850EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1E785EB-3B76-4E15-9544-26FB18FD66C3</gtr:id><gtr:title>Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1870347e2af496b0b9457966c06cd96"><gtr:id>f1870347e2af496b0b9457966c06cd96</gtr:id><gtr:otherNames>Bursill CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>ZWFJpJWtgKx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF307E8D-B5B6-4EB2-A5E0-5A4640B87B2D</gtr:id><gtr:title>Delivery of large genomic DNA inserts &amp;gt;100 kb using HSV-1 amplicons.</gtr:title><gtr:parentPublicationTitle>Current gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f056c409aede7073750d20c637e7b07f"><gtr:id>f056c409aede7073750d20c637e7b07f</gtr:id><gtr:otherNames>Hibbitt OC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1566-5232</gtr:issn><gtr:outcomeId>C2A369D203A</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400144</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>